Descriptor English: | Angiotensin II | ||||||
Descriptor Spanish: |
Angiotensina II
| ||||||
Descriptor Portuguese: | Angiotensina II | ||||||
Descriptor French: | Angiotensine-II | ||||||
Entry term(s): |
5 L Isoleucine Angiotensin II 5-L-Isoleucine Angiotensin II ANG-(1-8)Octapeptide Angiotensin II, 5-L-Isoleucine Angiotensin II, Ile(5)- Angiotensin II, Isoleucine(5)- Angiotensin II, Val(5)- Angiotensin II, Valine(5)- Angiotensin-(1-8) Octapeptide Isoleucine(5)-Angiotensin Isoleucyl(5)-Angiotensin II Valyl(5)-Angiotensin II |
||||||
Tree number(s): |
D06.472.699.094.078 D12.644.400.070.078 D12.644.456.073.041 D12.644.548.058.078 D12.776.631.650.070.078 D23.469.050.050.050 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D000804 | ||||||
Scope note: | An octapeptide that is a potent but labile vasoconstrictor. It is produced from angiotensin I after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME. The amino acid in position 5 varies in different species. To block VASOCONSTRICTION and HYPERTENSION effect of angiotensin II, patients are often treated with ACE INHIBITORS or with ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS. |
||||||
Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AN analysis BI biosynthesis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis DE drug effects DF deficiency EC economics GE genetics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PH physiology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||||
Pharm Action: |
Vasoconstrictor Agents |
||||||
Registry Number: | 11128-99-7 | ||||||
CAS Type 1 Name: | Angiotensin II | ||||||
Public MeSH Note: | 1974; see ANGIOTENSIN 1971-1973, see ANGIOTENSIN 1967-1970; ANGIOTENSIN was heading 1964-1978, was HYPERTENSIN 1963 (HYPERTENSIN see ANGIOTENSIN 1964-1965, see ANGIOTENSIN AMIDE 1966-1973); ANGIOTENSIN II, ILE(5)- was indexed under ANGIOTENSIN II 1981-1999, and ISOLEUCINE 1975-1981 |
||||||
History Note: | 1974(1963); for ANGIOTENSIN II, ILE(5)- use ANGIOTENSIN II (NM) 1974-1999 |
||||||
Related: |
Renin-Angiotensin System
MeSH | ||||||
DeCS ID: | 22334 | ||||||
Unique ID: | D000804 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 1974/01/01 | ||||||
Date of Entry: | 1999/01/01 | ||||||
Revision Date: | 2016/07/05 |
-
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Biological Factors [D23]Biological Factors
|
Angiotensin II
- Preferred
Angiotensin II, Val(5)-
- Narrower
Angiotensin II, Ile(5)-
- Narrower
Concept UI |
M0001202 |
Scope note | An octapeptide that is a potent but labile vasoconstrictor. It is produced from angiotensin I after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME. The amino acid in position 5 varies in different species. To block VASOCONSTRICTION and HYPERTENSION effect of angiotensin II, patients are often treated with ACE INHIBITORS or with ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS. |
Preferred term | Angiotensin II |
Entry term(s) |
ANG-(1-8)Octapeptide Angiotensin-(1-8) Octapeptide |
Concept UI |
M0001205 |
Preferred term | Angiotensin II, Val(5)- |
Entry term(s) |
Angiotensin II, Valine(5)- Valyl(5)-Angiotensin II |
Concept UI |
M0055996 |
Preferred term | Angiotensin II, Ile(5)- |
Entry term(s) |
5 L Isoleucine Angiotensin II 5-L-Isoleucine Angiotensin II Angiotensin II, 5-L-Isoleucine Angiotensin II, Isoleucine(5)- Isoleucine(5)-Angiotensin Isoleucyl(5)-Angiotensin II |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey